STEPHANIE MANDELL: Open Payments
NPI 1487983482 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 32 payments from 7 companies in 2025. Trend: 2023 $506 · 2024 $827 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $232 |
| Abbott Laboratories | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: Rybelsus, FREESTYLE LIBRE 3, Kerendia, Ozempic, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, Wegovy.
Industry payments across FL — which companies pay providers there.
